(Q38571627)

English

European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society.

scientific article published on 21 August 2015

European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 September 2017

European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society. (English)

1 reference

Europe PubMed Central

4 September 2017

0 references

Jesper Hastrup Svendsen

7

object named as

Jesper Hastrup Svendsen

0 references

Antonis S. Manolis

object named as

Antonis S Manolis

12

0 references

1

object named as

Gregory Y H Lip

1 reference

Europe PubMed Central

4 September 2017

Stefan D. Anker

9

object named as

Stefan D Anker

1 reference

Europe PubMed Central

4 September 2017

19

object named as

Cecilia Linde

1 reference

Europe PubMed Central

4 September 2017

Gerhard Hindricks

20

object named as

Gerhard Hindricks

1 reference

Europe PubMed Central

4 September 2017

25

object named as

Mitja Lainscak

1 reference

Europe PubMed Central

4 September 2017

15

object named as

Burkert Pieske

1 reference

Europe PubMed Central

4 September 2017

Wilhelm Haverkamp

11

object named as

Wilhelm Haverkamp

1 reference

Europe PubMed Central

4 September 2017

Tatjana S Potpara

6

object named as

Tatjana Potpara

1 reference

Europe PubMed Central

4 September 2017

17

object named as

Deirdre Lane

1 reference

Europe PubMed Central

4 September 2017

16

object named as

Bulent Gorenek

1 reference

Europe PubMed Central

4 September 2017

Jean-Yves Le Heuzey

5

object named as

Jean Yves Le Heuzey

1 reference

Europe PubMed Central

4 September 2017

13

object named as

Mina K Chung

1 reference

Europe PubMed Central

4 September 2017

Frank R Heinzel

2

object named as

Frank R Heinzel

1 reference

Europe PubMed Central

4 September 2017

José Ramón González Juanatey

4

object named as

Jose Rámon Gonzalez Juanatey

1 reference

Europe PubMed Central

4 September 2017

8

object named as

Marc A Vos

1 reference

Europe PubMed Central

4 September 2017

10

object named as

Andrew J Coats

1 reference

Europe PubMed Central

4 September 2017

Prashanthan Sanders

14

object named as

Prashanthan Sanders

1 reference

Europe PubMed Central

4 September 2017

Irene Savelieva

29

object named as

Irene Savelieva

1 reference

Europe PubMed Central

4 September 2017

author name string

Fiorenzo Gaita

3

1 reference

Europe PubMed Central

4 September 2017

Guiseppe Boriani

18

1 reference

Europe PubMed Central

4 September 2017

Hiroyuki Tsutsui

21

1 reference

Europe PubMed Central

4 September 2017

Shunichi Homma

22

1 reference

Europe PubMed Central

4 September 2017

Sheldon Brownstein

23

1 reference

Europe PubMed Central

4 September 2017

Jens Cosedis Nielsen

24

1 reference

Europe PubMed Central

4 September 2017

Marisa Crespo-Leiro

26

1 reference

Europe PubMed Central

4 September 2017

Massimo Piepoli

27

1 reference

Europe PubMed Central

4 September 2017

Petar Seferovic

28

1 reference

Europe PubMed Central

4 September 2017

publication date

21 August 2015

1 reference

Europe PubMed Central

4 September 2017

1 reference

Europe PubMed Central

4 September 2017

18

1 reference

Europe PubMed Central

4 September 2017

1

1 reference

Europe PubMed Central

4 September 2017

12-36

1 reference

Europe PubMed Central

4 September 2017

Clinical epidemiology of heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Atrial fibrillation and heart failure: a bad combination

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

CKD and sudden cardiac death: epidemiology, mechanisms, and therapeutic approaches

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

EURObservational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot).

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Risk of arterial embolization in 224 patients awaiting cardiac transplantation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Impact of atrial fibrillation on mortality and readmission in older adults hospitalized with heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Prognostic relevance of atrial fibrillation in patients with chronic heart failure on long-term treatment with beta-blockers: results from COMET.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Prognostic significance of atrial fibrillation is a function of left ventricular ejection fraction

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

New-onset atrial fibrillation is an independent predictor of in-hospital mortality in hospitalized heart failure patients: results of the EuroHeart Failure Survey

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Predictors of stroke in high-risk patients after acute myocardial infarction: insights from the VALIANT Trial.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Detection of atrial high-rate events by continuous home monitoring: clinical significance in the heart failure-cardiac resynchronization therapy population

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Sex differences in clinical characteristics and outcomes in elderly patients with heart failure and preserved ejection fraction: the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Atrial fibrillation and outcomes in heart failure with preserved versus reduced left ventricular ejection fraction

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Impact of atrial fibrillation on exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary study

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Atrial fibrillation associated with ivabradine treatment: meta-analysis of randomised controlled trials.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Stroke in patients with heart failure and reduced left ventricular ejection fraction

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies. The SEARCH-AF study.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

The impact of heart failure and left ventricular dysfunction in predicting stroke, thromboembolism, and mortality in atrial fibrillation patients: a systematic review

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Impact of heart failure with normal ejection fraction on the occurrence of ischaemic stroke in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Ejection fraction and outcomes in patients with atrial fibrillation and heart failure: the Loire Valley Atrial Fibrillation Project.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Predictors and prognostic implications of incident heart failure following the first diagnosis of atrial fibrillation in patients with structurally normal hearts: the Belgrade Atrial Fibrillation Study

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Rapid-rate nonsustained ventricular tachycardia found on implantable cardioverter-defibrillator interrogation: relationship to outcomes in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial).

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Sleep apnea and cardiovascular disease: an American Heart Association/american College Of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Counc

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Circadian variation in the frequency of sudden cardiac death

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Ventricular arrhythmia in congestive heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Prevalence and incidence of arrhythmias and sudden death in heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Statin therapy reduces the risk of ventricular arrhythmias, sudden cardiac death, and mortality in heart failure patients: a nationwide population-based cohort study.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: a report from the Italian network on congestive heart failure.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Heart failure with preserved ejection fraction: clinical characteristics of 4133 patients enrolled in the I-PRESERVE trial.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Sudden death in heart failure associated with reduced left ventricular function: substrates, mechanisms, and evidence-based management, Part II.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: results from the Triggers Of Ventricular Arrhythmias (TOVA) study

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Sudden cardiac death in heart failure patients with preserved ejection fraction.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC).

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Classification of atrial flutter and regular atrial tachycardia according to electrophysiologic mechanism and anatomic bases: a statement from a joint expert group from the Working Group of Arrhythmias of the European Society of Cardiology and the N

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Prognostic importance of defibrillator shocks in patients with heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Randomized controlled study of detection enhancements versus rate-only detection to prevent inappropriate therapy in a dual-chamber implantable cardioverter-defibrillator.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Ablation of atrial tachycardia and atrial flutter in heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Cardiac resynchronization therapy in patients with atrial fibrillation: the CERTIFY study (Cardiac Resynchronization Therapy in Atrial Fibrillation Patients Multinational Registry).

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Chronic heart failure, chronotropic incompetence, and the effects of beta blockade

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Cardiovascular mortality and chronotropic incompetence in systolic heart failure: the importance of a reappraisal of current cut-off criteria.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Gro

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Use of reperfusion therapy for acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Hospital outcomes in patients presenting with congestive heart failure complicating acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2)

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Sudden death after myocardial infarction.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Heart failure and tachycardia-induced cardiomyopathy

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Tachycardiomyopathy: mechanisms and clinical implications.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Predictors of recovery of left ventricular dysfunction after ablation of frequent ventricular premature depolarizations.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Impact of radiofrequency ablation of frequent post-infarction premature ventricular complexes on left ventricular ejection fraction.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Drug induced QT prolongation: the measurement and assessment of the QT interval in clinical practice

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Frequency and predictors of tachycardia-induced cardiomyopathy in patients with persistent atrial flutter

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Long-term follow-up in patients with the permanent form of junctional reciprocating tachycardia treated with radiofrequency ablation.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Left bundle branch block as a risk factor for progression to heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Recovery from left ventricular dysfunction after ablation of frequent premature ventricular complexes

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Supraventricular tachycardia causing heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Left ventricular morphology and systolic function in sleep-disordered breathing: the Sleep Heart Health Study

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Comparison of cardiac structural and functional changes in obese otherwise healthy adults with versus without obstructive sleep apnea.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Sleep apnea, heart failure, and pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Effect of sleep apnea and continuous positive airway pressure on cardiac structure and recurrence of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO).

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO).

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Arrhythmias in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Balancing stroke and bleeding risks in patients with atrial fibrillation and renal failure: the Swedish Atrial Fibrillation Cohort study.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Amiodarone and torsades de pointes in patients with advanced heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Evolving role of sotalol in the management of ventricular tachyarrhythmias

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Class III antiarrhythmic agents in cardiac failure: lessons from clinical trials with a focus on the Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA).

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

What is the optimal serum potassium level in cardiovascular patients?

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Prevalence, therapeutic response, and outcome of ventricular tachycardia in the out-of-hospital setting: a comparison of monomorphic ventricular tachycardia, polymorphic ventricular tachycardia, and torsades de pointes

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

SCN5A mutations associate with arrhythmic dilated cardiomyopathy and commonly localize to the voltage-sensing mechanism.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Effects of left ventricular assist device therapy on ventricular arrhythmias.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Ventricular arrhythmias after left ventricular assist device

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Implantable defibrillator therapy for ventricular tachyarrhythmia in left ventricular assist device patients

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Role of implantable cardioverter-defibrillators in patients with continuous flow ventricular assist devices

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Pathophysiology and clinical management of cardiac sarcoidosis.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Decision making in advanced heart failure: a scientific statement from the American Heart Association

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Patterns of ectopy leading to increased risk of fatal or near-fatal cardiac arrhythmia in patients with depressed left ventricular function after an acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Sinus rhythm is associated with fewer heart failure symptoms: insights from the AFFIRM trial.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Differentiation of ventricular tachycardia from supraventricular tachycardia with aberration: value of the clinical history

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Ambulatory ventricular arrhythmias in patients with heart failure do not specifically predict an increased risk of sudden death. PROMISE (Prospective Randomized Milrinone Survival Evaluation) Investigators

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Prevalence and significance of nonsustained ventricular tachycardia in patients with premature ventricular contractions and heart failure treated with vasodilator therapy. Department of Veterans Affairs CHF STAT Investigators

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Clinical relevance of slow ventricular tachycardia in heart failure patients with primary prophylactic implantable cardioverter defibrillator indication

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Effect of long-detection interval vs standard-detection interval for implantable cardioverter-defibrillators on antitachycardia pacing and shock delivery: the ADVANCE III randomized clinical trial

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Rationale and design of REVEAL AF: a prospective study of previously undiagnosed atrial fibrillation as documented by an insertable cardiac monitor in high-risk patients

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin: the SAMe-TT₂R₂ score.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Dabigatran compared with warfarin in patients with atrial fibrillation and symptomatic heart failure: a subgroup analysis of the RE-LY trial.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Efficacy and safety of rivaroxaban in patients with heart failure and nonvalvular atrial fibrillation: insights from ROCKET AF.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Left ventricular systolic dysfunction, heart failure, and the risk of stroke and systemic embolism in patients with atrial fibrillation: insights from the ARISTOTLE trial

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Rhythm versus rate control therapy and subsequent stroke or transient ischemic attack in patients with atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Prevalence of silent cerebral ischemia in paroxysmal and persistent atrial fibrillation and correlation with cognitive function.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Increased mortality after dronedarone therapy for severe heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: observations from the veterans affairs congestive heart failure survival trial of antiarrhythmic therapy (CHF-STAT). The Dep

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Catheter ablation for atrial fibrillation in congestive heart failure.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Pulmonary vein isolation for the treatment of atrial fibrillation in patients with impaired systolic function.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Clinical outcomes of catheter substrate ablation for high-risk patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Catheter ablation of paroxysmal atrial fibrillation improves cardiac function: a prospective study on the impact of atrial fibrillation ablation on left ventricular function assessed by magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Pulmonary-vein isolation for atrial fibrillation in patients with heart failure.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Left ventricular systolic dysfunction by itself does not influence outcome of atrial fibrillation ablation.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Success of ablation for atrial fibrillation in isolated left ventricular diastolic dysfunction: a comparison to systolic dysfunction and normal ventricular function

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Radiofrequency ablation for persistent atrial fibrillation in patients with advanced heart failure and severe left ventricular systolic dysfunction: a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Long-term results of transcatheter atrial fibrillation ablation in patients with impaired left ventricular systolic function

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Impact of atrial fibrillation-induced tachycardiomyopathy in patients undergoing pulmonary vein isolation.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

A randomized trial to assess catheter ablation versus rate control in the management of persistent atrial fibrillation in heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Meta-analysis of the effectiveness and safety of catheter ablation of atrial fibrillation in patients with versus without left ventricular systolic dysfunction

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Catheter ablation for atrial fibrillation in patients with left ventricular systolic dysfunction. A systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Catheter ablation of atrial fibrillation in patients with left ventricular systolic dysfunction: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Catheter ablation for atrial fibrillation: are results maintained at 5 years of follow-up?

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Carvedilol alone or in combination with digoxin for the management of atrial fibrillation in patients with heart failure?

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Lenient vs. strict rate control in patients with atrial fibrillation and heart failure: a post-hoc analysis of the RACE II study.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Cardiac resynchronization therapy in patients undergoing atrioventricular junction ablation for permanent atrial fibrillation: a randomized trial.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Biventricular pacing improves cardiac function and prevents further left atrial remodeling in patients with symptomatic atrial fibrillation after atrioventricular node ablation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Cardiac resynchronization therapy after atrioventricular junction ablation for symptomatic atrial fibrillation: a meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Amiodarone for the prevention of sudden cardiac death: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: the ALPHEE study

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Mechanisms of ranolazine's dual protection against atrial and ventricular fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Nonsustained ventricular tachycardia in severe heart failure. Independent marker of increased mortality due to sudden death. GESICA-GEMA Investigators

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Ambulatory ECG-based T-wave alternans predicts sudden cardiac death in high-risk post-MI patients with left ventricular dysfunction in the EPHESUS study

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Preserved heart rate variability identifies low-risk patients with nonischemic dilated cardiomyopathy: results from the DEFINITE trial.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Magnetic resonance estimates of the extent and heterogeneity of scar tissue in ICD patients with ischemic cardiomyopathy predict ventricular arrhythmia.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

The clinical value of cardiac sympathetic imaging in heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Epidemiology of Heart Failure and Left Ventricular Systolic Dysfunction after Acute Myocardial Infarction: Prevalence, Clinical Characteristics, and Prognostic Importance

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Implantable cardioverter-defibrillators after myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Frequency of sudden cardiac death among acute myocardial infarction survivors with optimized medical and revascularization therapy

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Incidence of sudden cardiac death after ventricular fibrillation complicating acute myocardial infarction: a 5-year cause-of-death analysis of the FAST-MI 2005 registry

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Catheter ablation for the treatment of electrical storm in patients with implantable cardioverter-defibrillators: short- and long-term outcomes in a prospective single-center study.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Catheter ablation of ventricular fibrillation triggers and electrical storm

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC)

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Early EPS/ICD strategy in survivors of acute myocardial infarction with severe left ventricular dysfunction on optimal beta-blocker treatment. The BEta-blocker STrategy plus ICD trial

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Early eplerenone treatment in patients with acute ST-elevation myocardial infarction without heart failure: the Randomized Double-Blind Reminder Study

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Wearable cardioverter-defibrillator use in patients perceived to be at high risk early post-myocardial infarction.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Home use of automated external defibrillators for sudden cardiac arrest

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Sudden cardiac death and left ventricular ejection fraction during long-term follow-up after acute myocardial infarction in the primary percutaneous coronary intervention era: results from the HIJAMI-II registry

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Incidence of and outcomes associated with ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Time dependence of mortality risk and defibrillator benefit after myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Clinical practice of defibrillator implantation after myocardial infarction: impact of implant time: results from the PreSCD II registry

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Cardiac resynchronization in chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

The effect of cardiac resynchronization on morbidity and mortality in heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Cardiac-resynchronization therapy for the prevention of heart-failure events.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Cardiac-resynchronization therapy for mild-to-moderate heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Cardiac-resynchronization therapy in heart failure with a narrow QRS complex

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Ventricular arrhythmias after left ventricular assist device implantation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Ventricular arrhythmias during left ventricular assist device support.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

The role of implantable cardioverter-defibrillators in patients with continuous flow left ventricular assist devices

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE).

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Acute heart failure in the elderly: differences in clinical characteristics, outcomes, and prognostic factors in the VERITAS Study.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

The impact of arrhythmias in acute heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Effect of levosimendan on the short-term clinical course of patients with acutely decompensated heart failure.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Mortality associated with atrial fibrillation in patients with myocardial infarction: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Electrical storm is an independent predictor of adverse long-term outcome in the era of implantable defibrillator therapy.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Electrical storm and heart failure worsening in implantable cardiac defibrillator patients

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Long-term outcomes of catheter ablation of atrial fibrillation: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Incidence, predictors, and temporal trends of sudden cardiac death after heart transplantation.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

The efficacy of implantable cardioverter-defibrillators in heart transplant recipients: results from a multicenter registry

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Brain natriuretic peptide for the prediction of sudden cardiac death and ventricular arrhythmias: a meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Clinical and serum-based markers are associated with death within 1 year of de novo implant in primary prevention ICD recipients.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Temporal Relations of Atrial Fibrillation and Congestive Heart Failure and Their Joint Influence on Mortality

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

2012 focused update of the ESC Guidelines for the management of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Executive Summary: Heart Disease and Stroke Statistics—2014 Update

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Stroke and Bleeding in Atrial Fibrillation with Chronic Kidney Disease

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Overview and meta-analysis of randomised trials of amiodarone in chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Defibrillator implantation early after myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Optimal heart failure therapy and successful cardioversion in heart failure patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Improving survival for patients with atrial fibrillation and advanced heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Atrial fibrillation or flutter on initial electrocardiogram is associated with worse outcomes in patients admitted for worsening heart failure with reduced ejection fraction: Findings from the EVEREST Trial

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

EHRA/HRS/APHRS expert consensus on ventricular arrhythmias

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Suppression of Central Sleep Apnea by Continuous Positive Airway Pressure and Transplant-Free Survival in Heart Failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Comparative Effectiveness of Rhythm Control vs Rate Control Drug Treatment Effect on Mortality in Patients With Atrial Fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Risk of sudden death and outcome in patients with hypertrophic cardiomyopathy with benign presentation and without risk factors

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Device-Detected Atrial Tachyarrhythmias Predict Adverse Outcome in Real-World Patients With Implantable Biventricular Defibrillators

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Screening to identify unknown atrial fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

The Euro Heart Failure Survey of The EUROHEART Survey Programme: A survey on the quality of care among patients with heart failure in Europe

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

QT dispersion and sudden unexpected death in chronic heart failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Reversal of Left Ventricular Dysfunction Following Ablation of Atrial Fibrillation

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Electrical Remodeling of the Atria in Congestive Heart Failure

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUV191

21 January 2018

Identifiers

10.1093/EUROPACE/EUV191

1 reference

Europe PubMed Central

4 September 2017

1 reference

Europe PubMed Central

4 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38571627&oldid=1743563171"